Inventor
CAO GANFENG
US33 patents
⚠️ This page may combine multiple inventors who share the name “CAO GANFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
25 patentsUS9221845B2Dec 29, 2015
Processes and intermediates for making a JAK inhibitor
INCYTE CORP55 citations98
US8987443B2Mar 24, 2015
Processes and intermediates for making a JAK inhibitor
INCYTE CORP79 citations97
US11001571B2May 11, 2021
Bipyrazole derivatives as JAK inhibitors
INCYTE CORP15 citations94
US10329255B2Jun 25, 2019
Salts of an LSD1 inhibitor
INCYTE CORP15 citations93
US9862705B2Jan 9, 2018
Salts of a pim kinase inhibitor
INCYTE CORP13 citations92
US11591318B2Feb 28, 2023
Bipyrazole derivatives as JAK inhibitors
INCYTE CORP6 citations86
US7511050B2Mar 31, 2009
Purinone derivatives as HM74A agonists
INCYTE CORP14 citations84
US7307086B2Dec 11, 2007
3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
INCYTE CORP21 citations84
US10723700B2Jul 28, 2020
Salts of an LSD1 inhibitor
INCYTE CORP7 citations83
US9714233B2Jul 25, 2017
Processes and intermediates for making a JAK inhibitor
INCYTE CORP6 citations83
US7834021B2Nov 16, 2010
3-aminopyrrolidine derivatives as modulators of chemokine receptors
INCYTE CORP4 citations74
US7678798B2Mar 16, 2010
Piperazinylpiperidine derivatives as chemokine receptor antagonists
INCYTE CORP5 citations74
US7462624B2Dec 9, 2008
Purinone derivatives as HM74a agonists
INCYTE CORP8 citations74
US11905275B2Feb 20, 2024
Bipyrazole derivatives as JAK inhibitors
INCYTE CORP2 citations73
US11505540B2Nov 22, 2022
Salts of a Pim kinase inhibitor
INCYTE CORP1 citations72
US12247020B2Mar 11, 2025
Bipyrazole derivatives as JAK inhibitors
INCYTE CORP0 citations63
US7902205B2Mar 8, 2011
Purinone derivatives as HM74A agonists
INCYTE CORP3 citations63
US7618970B2Nov 17, 2009
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
INCYTE CORP5 citations63
US12043614B2Jul 23, 2024
Salts of a Pim kinase inhibitor
INCYTE CORP0 citations62
US11498900B2Nov 15, 2022
Salts of an LSD1 inhibitor
INCYTE CORP0 citations62
US8362003B2Jan 29, 2013
3-aminopyrrolidine derivatives as modulators of chemokine receptors
INCYTE CORP2 citations62
US9067921B2Jun 30, 2015
Piperazinylpiperidine derivatives as chemokine receptor antagonists
INCYTE CORP0 citations52
US8039478B2Oct 18, 2011
Purinone derivatives as HM74A agonists
INCYTE CORP1 citations52
US7863285B2Jan 4, 2011
Purinone derivatives as HM74A agonists
INCYTE CORP1 citations52
US8729063B2May 20, 2014
3-aminopyrrolidine derivatives as modulators of chemokine receptors
INCYTE CORP0 citations49
XUE CHU-BIAO
4 patentsUS8268826B2Sep 18, 2012
Piperazinylpiperidine derivatives as chemokine receptor antagonists
XUE CHU-BIAO3 citations61
US8680104B2Mar 25, 2014
Piperazinylpiperidine derivatives as chemokine receptor antagonists
XUE CHU-BIAO0 citations51
US8563582B2Oct 22, 2013
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
XUE CHU-BIAO0 citations51
US8470827B2Jun 25, 2013
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
XUE CHU-BIAO0 citations51